Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

Mise à jour : Il y a 4 ans
Référence : NCT00321854

Femme et Homme

Extrait

This is a double blind, placebo-controlled clinical trial of 15 months duration designed to examine early Mirapex (pramipexole) treatment vs. delayed Mirapex (pramipexole) treatment in patients with new onset Parkinsons disease


Critère d'inclusion

  • Parkinson disease


Liens